In summary, our research verified that STEAP4 exhibits tumor heterogeneity in HNSCC and OSCC and can serve as an independent predictor for assessing the prognosis of OSCC patients. This evidence concerns the gene STEAP4 and head and neck squamous cell carcinoma.